FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069299 [Registered on: 20/06/2024] Trial Registered Prospectively
Last Modified On: 19/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of Ropivacaine with Levobupivacaine for epidural analgesia in Lower limb orthopedic surgeries 
Scientific Title of Study   To evaluate the efficacy of epidural analgesia with Ropivacaine 0.2% and levobupivacaine 0.25% in lower limb orthopaedic surgeries. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Samruddhi Dhamdhere 
Designation  PG Resident 1st year 
Affiliation  Smt Kashibai Navale Medical College and General Hospital, Pune 
Address  Operation theatre complex 1.Smt Kashibai Navale Medical College and General Hospital, Narhe, Pune 411041

Pune
MAHARASHTRA
411041
India 
Phone  7028190464  
Fax    
Email  drsamruddhi22@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Neha Panse 
Designation  Professor 
Affiliation  Smt Kashibai Navale Medical College and General Hospital, Pune 
Address  Department of Anesthesiology. Smt kashibai Navale Medical College Pune.
Operation Theatre complex, new building,Smt Kashibai Navale Medical College and General Hospital, Pune
Pune
MAHARASHTRA
411046
India 
Phone  9689495891  
Fax    
Email  drnehaghule@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Neha Panse 
Designation  Professor 
Affiliation  Smt Kashibai Navale Medical College and General Hospital, Pune 
Address  Department of Anesthesiology, Smt kashibai Navale Medical College,Pune
Operation Theatre complex, new building,Smt Kashibai Navale Medical College and General Hospital, Pune
Pune
MAHARASHTRA
411046
India 
Phone  9689495891  
Fax    
Email  drnehaghule@gmail.com  
 
Source of Monetary or Material Support  
Smt Kashibai Navale Medical College and General Hospital, Narhe, Pune 411041  
 
Primary Sponsor  
Name  Samruddhi Dhamdhere 
Address  Operation theatre complex 1, Smt Kashibai Navale Medical College and General Hospital, Narhe, Pune 411041  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR NEHA PANSE  Kashibai Navale Medical College   Operation Theatre Complex Theatre no.6,7,8
Pune
MAHARASHTRA 
9689495891

drnehaghule@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Smt. Kashibai Navale Medical College and General Hospital Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M800||Age-related osteoporosis with current pathological fracture,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  0.2% Ropivacaine  0.2 % Ropivacaine at 0.2 mg/kg/hr given epiduraly postoperatively 
Comparator Agent  0.25% levobupivacaine  0.25% Levobupivacaine epiduraly given postoperatively for 48 hours.Levobupivacaine at 0.2 mg/kg/hr given epiduraly postoperatively 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. ASA physical status 1 and 2
2. Written and informed consent given by patient.
3. Patient scheduled for eledtive lower limb orthopedic surgeries under combined spinal epidural anesthesia. 
 
ExclusionCriteria 
Details  1.Refusal for participation.
2.Known allergy or contraindication to the drugs used.
3.Cerebrovascular disease.
4.Intracranial hypertension 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduction in the pain by epidural analgesia in lower limb orthopedic surgeries.  T0: First test dose intraoperatively
T60: 60 min after test dose
T150: 150 min after test does
T1: 1 hour postoperatively
T2: 2 hours postoperatively
T4: 4 hours postoperatively
T8: 8 hours postoperatively
T12: 12 hours postoperatively
T16: 16 hours postoperatively
T24: 24 hours postoperatively
T36: 36 hour postoperatively
T48: 48 hour postoperatively 
 
Secondary Outcome  
Outcome  TimePoints 
1.Lower incidence of hypotension and bradycardia
2.Incidence of PONV 
T0: First test dose intraoperatively
T60: 60 min after test dose
T150: 150 min after test does
T1: 1 hour postoperatively
T2: 2 hours postoperatively
T4: 4 hours postoperatively
T8: 8 hours postoperatively
T12: 12 hours postoperatively
T16: 16 hours postoperatively
T24: 24 hours postoperatively
T36: 36 hour postoperatively
T48: 48 hour postoperatively 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   post operative pain is troublesome after orthopedic surgeries, effective pain relief causes early and smooth recovery. to provide effective analgesia we intend to compare 0.2% ropivacaine and 0.25% levobupivacaine. via epidural route. 
Close